Nasal drops from stem cells aim to heal stroke damage

NCT ID NCT07232563

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests whether nasal drops containing tiny particles from umbilical cord stem cells are safe for people who had an ischemic stroke. Nine patients will receive the drops four times over two weeks, alongside standard care. The main goal is to check for serious side effects, not yet to prove the treatment works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
stem cell vesicle nasal drops (hUC-MSC-sEV-001)
What this could lead to
If safe and effective, this could point toward a new way to help stroke patients recover without surgery or strong drugs.
What could go wrong
This is a very early, tiny safety trial with only 9 people. It may not show any benefit, and side effects or lack of effect are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • 253 Gongye Blvd Middle, Guangzhou, Guangdong, China 510280

    Guangzhou, Guangdong, 510000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.